BioSpace News Archive

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the London-based Great Ormond Street Hospital (GOSH) has received UK research ethics approval to commence a Phase II academic study of Telix’s investigational product, TLX66 (90Y-DTPA-besilesomab), in children with high-risk leukemia.

Technicolor Precision BioDevices (TPB), a member of the creative technology leader Technicolor (Euronext Paris: TCH, OTCQX: TCLRY), announces a collaboration with Scope Fluidics to manufacture cartridges for their BacterOMIC system.

InferVision AI has been selected to help monitor COVID-19 variants across the European Union.

Ainos, Inc. elected Ms. Hui-Lan (Celia) Wu as its new Chief Financial Officer

New study results for Tikomed’s platform lead drug candidate ILB® in the treatment of patients with amyotrophic lateral sclerosis (ALS), have now been published in the Journal of Personalized Medicine.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche.

In a first-in-human study, researchers at The Feinstein Institutes for Medical Research elicited the sense of touch through a minimally-invasive electrode brain implant.

Cell culture is a technique where cells are grown and studied under controlled conditions.

Custom Antibody Service is the service dealing with production of customized antibodies.

Sino Biological, Inc. announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047.